{"id":"W2944211448","doi":"10.1158/1538-7445.sabcs18-p4-13-06","title":"Abstract P4-13-06: Real-world experience using exemestane and everolimus in patients with hormone receptor positive/HER2 negative breast cancer with and without prior CDK4/6 inhibitor exposure","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Exemestane; Aromatase inhibitor; Internal medicine; Breast cancer; Discontinuation; Oncology; Lapatinib; Anastrozole; Everolimus; Cancer; Trastuzumab; Tamoxifen","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005987002,0.00007836754,0.0002010734,0.0003748123,0.0009395396,0.0007042426,0.0003504338,0.0001936265,0.001610559],"category_scores_gemma":[0.002875106,0.0001462216,0.0001785736,0.0009680884,0.0004681986,0.0003316888,0.000748342,0.0005270025,0.0002337205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002662635,"about_ca_system_score_gemma":0.003047944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07507272,"about_ca_topic_score_gemma":0.146061,"domain_scores_codex":[0.9994015,0.0001700549,0.00006420577,0.00006796813,0.0001406768,0.0001556352],"domain_scores_gemma":[0.9970046,0.0004862077,0.001225419,0.00009829336,0.0003183011,0.0008673358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003782703,0.0002256166,0.9883521,0.0000381297,0.00002061458,0.00102652,0.001851975,0.000113881,0.0004250919,0.00003694843,0.0006208788,0.006909959],"study_design_scores_gemma":[0.00004494814,0.0009400183,0.9864655,0.00003218002,0.00002592656,0.003072526,0.005738975,0.0003430951,0.0003390818,0.00004197194,0.002938617,0.00001704162],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983791,0.0001081817,0.00004501905,0.0001436844,0.000002070894,0.00002528166,0.0003878054,0.000003108083,0.0009057607],"genre_scores_gemma":[0.9987986,0.0001734583,0.0001611729,0.0001426013,0.000008447143,0.0000140913,0.0003496846,0.00000319179,0.0003485864],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07507272,"threshold_uncertainty_score":0.1492715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02472914254492935,"score_gpt":0.3533755591893351,"score_spread":0.3286464166444057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}